Linde Weighs Potential Sale of Lincare Unit
The industrial gas company is evaluating options for its underperforming healthcare business segment.
Updated on Oct. 30, 2026 in Healthcare
Live Poll
Do you trust large corporations to handle the future of their underperforming business units effectively?
Linde is considering a potential sale of Lincare, an underperforming healthcare business based in the United States. Management recently discussed the unit's status during a quarterly earnings call.
Why it matters
The review signals a potential shift in strategy as the company seeks to manage assets that are currently underperforming relative to expectations. By isolating the business, leadership is taking a concrete step toward evaluating its future viability.
Linde has officially transferred Lincare into a separate reporting structure to facilitate its assessment. The company identified the unit as an underperforming segment during its third-quarter financial review.
The players
Linde
Linde is a multinational chemical company that functions as the world's largest industrial gas supplier.
Lincare
Lincare is a healthcare company providing respiratory care services and medical equipment across the United States.
The details
Linde management addressed the future of the healthcare subsidiary during a recent earnings call, signaling that they are exploring divestment possibilities. The company has moved the unit out of its primary Americas reporting segment to support this evaluation.
Timeline
Linde executives held their third-quarter earnings call during Q3 2026.
Market Landscape
This potential divestment marks a departure from the integration strategy established by the 2012 acquisition of Lincare by Linde. Such moves reflect a broader industry trend where diversified corporations shed underperforming assets to sharpen their operational focus.
Customers of the subsidiary should monitor for updates regarding service continuity or changes in management. The potential sale could eventually lead to transitions in brand ownership or operational service models for the healthcare provider.
The takeaway
Large conglomerates frequently reorganize their portfolios to maximize shareholder value by offloading segments that fail to meet performance targets. Investors and stakeholders should watch for official confirmation of a sale or a strategic turnaround plan.
Further reading
For more on the current state of the medical industry, visit the United States Healthcare section.
Source note: This article includes information reported by Gasworld.
Live Poll
Do you trust large corporations to handle the future of their underperforming business units effectively?
